|
|
 |
|
 |
|
Stephen A. Sherwin, M.D.
Chairman and Chief Executive Officer
Dr. Sherwin, chairman of the board and chief executive officer, joined
Cell Genesys in March 1990. Dr. Sherwin has served as chief executive
officer since our inception and, in March 1994, was elected to the
additional position of chairman of the board of directors. Dr. Sherwin
also served as president until July 2001, at which time Dr. Vallner
was appointed president. From 1983 to 1990, Dr. Sherwin held various
positions at Genentech, Inc., a biotechnology company, most recently
as vice president of clinical research. Prior to 1983, Dr. Sherwin
was on the staff of the National Cancer Institute. Dr. Sherwin currently
serves as the chairman of the board for Ceregene, Inc., a majority-owned
subsidiary of Cell Genesys and a company that he co-founded in 2001.
He was also a co-founder of Abgenix, Inc., a former subsidiary of
Cell Genesys. Dr. Sherwin currently serves as member of the board
of directors for Neurocrine Biosciences, Inc. and Rigel Pharmaceuticals,
Inc. and also serves as a board member of the Biotechnology Industry
Organization. He holds a B.A. in biology from Yale University and
an M.D. from Harvard Medical School and is board-certified in internal
medicine and medical oncology. |
|
|
|
